Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2005
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1571144A1 Hydroxyalkylated cyclic diamine compound
09/07/2005EP1571143A1 Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the transport of electrons of the respiratory chain in phytopathogenic fungal organisms
09/07/2005EP1571141A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569921A1 Ionic liquids comprising n(cf sb 3 /sb ) sb 2 /sb ] sp - /sp anions
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569908A2 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
09/07/2005EP1569907A1 Nicotinamide-based kinase inhibitors
09/07/2005EP1569906A1 Method for photochemical halogenation
09/07/2005EP1569904A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
09/07/2005EP1569895A1 Prodrugs of gaba analogs, compositions and uses thereof
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1187812B1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
09/07/2005CN1666577A Electronic devices made with electron transport and/or anti-quenching layers
09/07/2005CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1217937C Synthesis of intermediates useful in preparing tricyclic compounds
09/07/2005CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217699C Preventives or remedies for arrhythmia
09/06/2005US6939985 covalently coupling organic compounds by reacting an aromatic ring compound having a halogen or halogen-like substituent at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a base
09/06/2005US6939972 Process for producing 4-dimethyl amino pyridine (4-DMAP)
09/06/2005US6939967 Non-proteinogenic L-amino acids
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/06/2005US6939885 Sulfur compounds such as 4-tert-Butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide, used as chemokine receptor antagonists, antiinflamatory agents or as immunology modulators
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939882 Fungicides
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/06/2005US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents
09/06/2005US6939856 For use as extended release antihistamines
09/06/2005US6939578 Volatile copper(II) complexes for deposition of copper films by atomic layer deposition
09/06/2005CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080363A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080360A1 Compounds
09/01/2005WO2005080342A1 Pyridine derivatives and their use as cb2 receptor modulators
09/01/2005WO2005080341A1 Ionic uv-a sunscreens and compositions containing them
09/01/2005WO2005080340A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005079959A1 Advanced contaminant treatment system
09/01/2005WO2005079866A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005WO2005079865A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005WO2005079398A2 Drug conjugates
09/01/2005WO2005079378A2 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
09/01/2005WO2005079270A2 2-substituted and 4-substituted aryl nitrone compouds
09/01/2005WO2005021523A8 Piperazine substituted compounds used as calcium channel blockers
09/01/2005WO2005002519A3 Amphiphilic pyridinium compounds, method of making and use thereof
09/01/2005WO2004054991A8 Ionic liquids comprising [n(cf3)2]- anions
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192293 Vanilloid receptor VR1 modulators; pain, inflammation, traumatic injury, autoimmune disease; compounds are pyridine subsituted at 2 position with an amido-, sulfoamido- or thioamide-substituted (N-hetero)aryl ring
09/01/2005US20050192284 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
09/01/2005US20050192283 Fused-aryl and heteroaryl derivatives and methods of their use
09/01/2005US20050192281 Nitrone compounds, prodrugs and pharmaceuticals compositons of the same to treat human disorders
09/01/2005CA2556270A1 2-substituted and 4-substituted aryl nitrone compouds
09/01/2005CA2556268A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2555970A1 Therapeutic amide derivatives
09/01/2005CA2555963A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005CA2555959A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
09/01/2005CA2555814A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
09/01/2005CA2555641A1 Drug conjugates
09/01/2005CA2555071A1 Histamine-3 receptor modulators
09/01/2005CA2554686A1 Compounds
09/01/2005CA2554312A1 Advanced contaminant treatment system
08/2005
08/31/2005EP1568694A1 N-heteroaryl-para-phenylene diamines for colouring hair
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1568691A1 Erythropoietin production accelerator
08/31/2005EP1568690A1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005EP1567499A1 Substituted pyridyloxyalkylamides and their use as fungicides
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005EP1567497A2 Pyridines for treating injured mammalian nerve tissue
08/31/2005EP1567494A1 Methods for preparing phenylalkyne derivatives
08/31/2005EP1567486A2 Bis-aryl sulfonamides
08/31/2005EP1430057B1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1224192B1 Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP0989973B1 Chalcones having antiproliferative activity
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662503A Process for preparation of 2-pyridone compounds substituted with phenoxy group
08/31/2005CN1662502A Cyanoguanidine produgs
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1662484A Process for preparing (r)-aryloxypropionic acid ester derivatives
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma
08/31/2005CN1660842A Preparation of 4-hydroxy-3-nitro-2(1h)-pyridone from 2-hydroxy-3-cyano-4-methoxypyridine
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs